Biosimilar Monoclonal Antibodies: Practical Guide

This book addresses a significant need by covering all aspects of biosimilar development, specifically focusing on monoclonal antibody (mAb) drugs. It describes the science and process involved in developing these biosimilars, including preclinical, clinical, regulatory, and manufacturing aspects.

Readers are guided through the complex landscape of developing biosimilar versions of mAb drugs, with the help of flow charts, tables, and figures that clearly illustrate processes. This makes the book comprehensible and accessible to a wide range of readers.

In addition, the book includes a review of FDA-approved mAb drugs, serving as a quick reference to provide readers with facts and useful information on the subject. It also examines new technologies and strategies aimed at improving biosimilar mAbs.

Overall, this book is a valuable resource for anyone involved in the development of biosimilar mAb drugs. Its comprehensive coverage of the topic, easy-to-understand format, and inclusion of relevant information make it a must-read for those in the field.

product information: